Lacosamide Adroiq ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

lacosamide adroiq

extrovis eu ltd. - lakosamid - epilepsi - antiepileptics, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Lacosamide Accord ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

lacosamide accord

accord healthcare s.l.u. - lakosamid - epilepsi - antiepileptics, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy•         in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. •         in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Lacosamide UCB ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

lacosamide ucb

ucb pharma s.a. - lakosamid - epilepsier, delvis - antiepileptics, - lacosamide ucb er indisert som monoterapi og tilleggsbehandling ved behandling av delvis-utbruddet anfall med eller uten sekundær generalisering hos voksne, ungdom og barn fra 4 år med epilepsi.

Vimpat ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

vimpat

ucb pharma sa - lakosamid - epilepsi - antiepileptics, - vimpat er indisert som monoterapi og tilleggsbehandling ved behandling av partielle anfall med eller uten sekundær generalisering hos voksne, ungdom og barn fra 4 år med epilepsi.

Furosemide Kalceks 10 mg/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

furosemide kalceks 10 mg/ ml

as kalceks - furosemid - injeksjons-/infusjonsvæske, oppløsning - 10 mg/ ml

Furosemide Baxter 10 mg/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

furosemide baxter 10 mg/ ml

baxter holding b.v. - furosemid - injeksjonsvæske, oppløsning - 10 mg/ ml